Heather Lambert
Women's Health · Gordonsville, TNNPI 1023099074
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 403 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by Novo Nordisk at 25.8% of the total. Among women's health clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 403 payments — averaging $13.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$709
- Lilly USA, LLC$658
- AstraZeneca$369
- Pfizer$237
- Biohaven Pharmaceuticals, Inc.$232
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,483100%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,509 in reported general payments places this provider in the 95th percentile of 202 women's health providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 113 | $122,943 |
| JardianceEmpagliflozin | 164 | $116,991 |
| TrulicityDulaglutide | 89 | $100,231 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 90 | $60,922 |
| MounjaroTirzepatide | 48 | $50,228 |
| VraylarCariprazine Hcl | 32 | $44,531 |
| EliquisApixaban | 43 | $43,181 |
| VascepaIcosapent Ethyl | 74 | $30,850 |
| Tresiba Flextouch U-200Insulin Degludec | 24 | $30,602 |
| TradjentaLinagliptin | 36 | $29,091 |
| MyrbetriqMirabegron | 54 | $23,654 |
| Tresiba Flextouch U-100Insulin Degludec | 44 | $23,563 |
| LinzessLinaclotide | 33 | $18,229 |
| TrintellixVortioxetine Hydrobromide | 39 | $17,602 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 26 | $16,670 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $658 | $150,459137 claims |
| Boehringer IngelheimJardiance, Tradjenta | $118 | $146,083200 claims |
| Novo NordiskOzempic, Rybelsus | $1,424 | $137,480129 claims |
| AbbVieVraylar, Linzess, Qulipta, Ubrelvy, Restasis | $709 | $97,130103 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $41 | $75,053123 claims |
| PfizerEliquis | $237 | $43,18143 claims |
| Johnson & JohnsonXarelto, Invokana | $17 | $23,65042 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $369 | $22,21947 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $227 | $17,60239 claims |
| BayerKerendia | $135 | $15,10417 claims |
| Redhill Biopharma Inc.Movantik | $16 | $7,82219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 202 women's health providers in Tennessee.
Other women's health in Gordonsville
- Haley WoodFranklin$92K
- Dana DemossNashville$76K
- Royanne MooreNashville$29K
- Laurie TompkinsBrentwood$27K
- Lana HirschNashville$24K
- Yoshie DarnallNashville$10K
- Lisa GoehringNashville$9K
- Anya ZerillaKnoxville$8K
- Catherine KingeryKnoxville$7K
- Lindsey BakshNashville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.